Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VARIVAX in Healthy Indian Children
NCT00496327Phase 3Completed
- Sponsor
- Merck & Co.
- Start
- Jun 2005
- Primary completion
- Oct 2005
- Modality
- Prophylactic Vaccines, DNA Vaccines, Live Biotherapeutic Products
01
Overview
A Phase 3 trial of varicella virus vaccine live in varicella (VZV), sponsored by Merck & Co.. Started Jun 2005; status: completed.
02
Drugs
varicella virus vaccine live
03
Conditions
varicella (VZV)
Beyond the preview
Go deeper on NCT00496327.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00496327.